Loading…

See where your brand stands in AI answers

Free. About a minute. No sign-up.

Know where you stand. Find your next opportunity.

Products

Brands
Markets
Topics
Work with us
Pricing

Resources

Research
Methodology
Blog
MCP
For AI

Compare

Parse vs Profound
Parse vs Peec AI
Parse vs AthenaHQ
Parse vs Scrunch
Parse vs Otterly.AI
All comparisons

Company

About
Dimitry Apollonsky
Contact us
Corrections

© 2026 Parse, Inc. All rights reserved.

Privacy Policy Terms of Service

Sign in Check your brand

What AI says about BT-001 | Parse

Track BT-001. Free.

Brands

BT-001

What AI says about BT-001

Track BT-001 free

B

AI named BT-001 from August 2026 to September 2026.

BT-001 in AI’s own words

Question: What's the best digital therapeutic for managing type 2 diabetes?

ChatGPT SearchSep 2, 2026

Best evidence for a “pure” behavioral digital therapeutic: the CBT-based BT-001 program

Ask ChatGPT yourself (opens in a new tab)

Question: What's the best digital therapeutic for managing type 2 diabetes?

ChatGPT SearchAug 13, 2026

Received FDA De Novo authorization for BT-001, a prescription software device

Ask ChatGPT yourself (opens in a new tab)

Track BT-001: see where AI mentions it and what to do next.

Competitors

Omada Health and Virta Health appeared in every answer that named BT-001.

Omada Health

See where AI mentions BT-001

Better Therapeutics

BlueStar Diabetes

Sources AI cites

AI leaned on diabetesjournals.org, pubmed.ncbi.nlm.nih.gov, and accessdata.fda.gov in the answers that named BT-001.

diabetesjournals.org (opens in a new tab)20%
pubmed.ncbi.nlm.nih.gov (opens in a new tab)20%
accessdata.fda.gov (opens in a new tab)10%
doi.org (opens in a new tab)10%
ncbi.nlm.nih.gov (opens in a new tab)10%

Questions and answers

What's the best digital therapeutic for managing type 2 diabetes?
Excerpts where BT-001 appeared in the AI's answer
ChatGPT SearchSep 2, 2026, ChatGPT Search
Best evidence for a “pure” behavioral digital therapeutic: the CBT-based BT-001 program
ChatGPT SearchAug 13, 2026, ChatGPT Search
Received FDA De Novo authorization for BT-001, a prescription software device